Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma

The treatment landscape for mantle cell lymphoma (MCL) is rapidly evolving toward the incorporation of novel and biologically targeted pharmaceuticals with improved disease activity and gentler toxicity profiles compared with conventional chemotherapeutics. Upfront intensive treatment of MCL include...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Fengting, Gopal, Ajay K., Graf, Solomon A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374432/
https://www.ncbi.nlm.nih.gov/pubmed/28287430
http://dx.doi.org/10.3390/ph10010028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374432/
https://www.ncbi.nlm.nih.gov/pubmed/28287430
http://dx.doi.org/10.3390/ph10010028

Ejemplares similares